Written by the Nuvirox Research Team
- Being 'easily fatigued' is one of six official DSM-based associated symptoms of generalized anxiety disorder, alongside restlessness, poor concentration, irritability, muscle tension, and sleep disturbance.
- GAD has a 12-month prevalence of roughly 1.8% to 2.9% among U.S. adults, and research has found significantly higher fatigue scores in people with GAD than in those with personality disorders or dysthymia.
- A systematic review of fatigue across common mental disorders found fatigue is a genuine, measurable symptom of anxiety disorders, not simply a byproduct of poor sleep from worry.
Why does anxiety make you physically tired, not just mentally on edge?
Short answer: because fatigue is one of the formal, diagnostic-criteria-level symptoms of generalized anxiety disorder (GAD), not a downstream side effect of it. Under DSM-IV and DSM-5 criteria, a GAD diagnosis requires excessive, difficult-to-control worry about multiple areas of life, plus at least three of six associated symptoms: restlessness or feeling keyed up, being easily fatigued, difficulty concentrating or mind going blank, irritability, muscle tension, and sleep disturbance. Fatigue sits directly alongside the more commonly discussed anxiety symptoms as a core, recognized part of the clinical picture.
How common is GAD, and how strong is the fatigue link?
GAD affects a meaningful minority of adults, and the fatigue association is specifically measurable in research, not just anecdotal. The 12-month prevalence of GAD is estimated between 0.9% among adolescents and 2.9% among adults in U.S. community samples, with a lifetime prevalence estimated between 6% and 9% in some analyses. A study of 375 psychiatric outpatients, 28% of whom had GAD, found significantly more patients with GAD reported high levels of fatigue than patients with personality disorders or dysthymia, a finding that helps distinguish GAD-related fatigue from fatigue that's simply present across most psychiatric conditions generally.
A separate study administering the Multidimensional Fatigue Inventory to 360 patients with panic disorder (a related but distinct anxiety condition) and 1,004 healthy controls found general and physical fatigue scores were significantly higher in patients than controls, reinforcing that anxiety-spectrum conditions carry a measurable physical fatigue burden beyond the psychological experience of worry itself.
Is this "real" fatigue or just poor sleep from worrying?
The research treats it as a distinct symptom, not simply a knock-on effect of disrupted sleep. A systematic review of fatigue prevalence across common mental disorders, including mood, anxiety, personality, and trauma-related disorders, specifically catalogued fatigue as one of several core symptom clusters worth independently measuring in anxiety populations, rather than folding it entirely into the sleep-disturbance criterion. That said, sleep disturbance is also a separate, official GAD criterion, so the two symptoms likely compound each other in most people's actual day-to-day experience rather than operating in isolation.
What the impact data shows
The functional impact of this fatigue is substantial, not marginal. Clinical literature on GAD estimates that people with the condition lose an average of about 6 days a month to missed or shortened workdays, a meaningful functional cost that reflects the combined weight of worry, fatigue, poor concentration, and the other criteria symptoms operating together. GAD also shows a bimodal age-of-onset pattern, with peaks in the late teens to early twenties and again in the 30s and 40s, and individuals of European descent and those from developed countries report higher lifetime rates than individuals from developing countries or non-European backgrounds, according to epidemiological data, a pattern researchers attribute at least partly to differences in diagnostic access and reporting rather than a true biological difference in prevalence.
The honest counterweight: diagnostic tools and prevalence estimates for GAD vary meaningfully across studies. A scoping review of 48 studies estimating GAD prevalence found that while structured diagnostic interviews were the most common assessment tool, test accuracy wasn't consistently reported across studies, which the reviewers flagged as a real limitation on how precisely prevalence, and by extension the associated fatigue burden, can be pinned down across different populations.
What this article isn't
This is not a diagnostic tool, and persistent fatigue with worry is not the same as a confirmed GAD diagnosis, which requires a clinical evaluation against the full criteria, including duration (generally six months or more) and ruling out other medical or psychiatric explanations. If you take medication for anxiety, particularly an SSRI or SNRI, be aware that Sleep+ Restore's St. John's Wort and 5-HTP content, and NAD+ Restore's own formulation, both carry documented interaction considerations with certain psychiatric medications, so a conversation with your prescriber before adding any new supplement matters here specifically.
For related reading, see our pieces on NAD+ and antidepressant-related fatigue, what the evidence says about adrenal fatigue, and Why Do I Feel So Tired After Stopping Birth Control?.
What's typically involved in addressing GAD-related fatigue
Evidence-based treatment for GAD itself, cognitive behavioral therapy and, where appropriate, medication, remains the primary approach supported by clinical research, since the fatigue is one symptom within a larger, treatable clinical picture rather than a standalone problem. Sleep hygiene and stress-management strategies can help at the margins, but they address the sleep-disturbance criterion specifically rather than the fatigue criterion, which appears to have some independent basis in the anxiety disorder itself.
Frequently asked questions
Yes. 'Being easily fatigued' is one of six associated symptoms in the DSM criteria for GAD, alongside restlessness, poor concentration, irritability, muscle tension, and sleep disturbance.
Estimates vary by study; U.S. 12-month prevalence among adults is roughly 2.9%, with lifetime prevalence estimated between 6% and 9% in some analyses.
Research treats them as related but distinct: sleep disturbance is its own separate GAD criterion, and studies have found fatigue is elevated in anxiety populations independent of sleep-specific measures.
Clinical estimates suggest people with GAD lose an average of roughly 6 days a month to missed or shortened workdays, reflecting the combined impact of worry, fatigue, and concentration difficulties.
From Nuvirox
Why we formulated NAD+ Restore
None Each two-capsule serving provides 500 mg nicotinamide riboside chloride (NR), one of the two most-researched NAD+ precursors, within the dose range used in published human trials, alongside 150 mg trans-resveratrol and 50 mg quercetin, polyphenols studied alongside NAD+ pathways for cellular health support, plus 10 mg fenugreek-derived galactomannans to support absorption. If you are managing a medical condition or take prescription medication, talk with your doctor before adding any new supplement, including this one.
Every order is backed by a 60-day money-back guarantee, long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
Fatigue is a formally recognized, diagnostic-criteria-level symptom of generalized anxiety disorder, not merely a side effect of disrupted sleep or worry, and research finds it measurably elevated compared with several other psychiatric conditions. Persistent fatigue alongside chronic, hard-to-control worry is worth a clinical evaluation, since GAD is treatable and the fatigue tends to improve as the underlying condition is addressed.
References
- Generalized Anxiety Disorder. Focus, American Psychiatric Association Publishing. https://psychiatryonline.org/doi/full/10.1176/foc.2.3.346
- A systematic review of the prevalence of fatigue in common mental disorders. BMC Psychiatry. https://link.springer.com/article/10.1186/s12888-026-08094-x
- Generalized Anxiety Disorder (Symptoms). Center for the Treatment and Study of Anxiety, Perelman School of Medicine, University of Pennsylvania. https://www.med.upenn.edu/ctsa/general_anxiety_symptoms.html
- Tools used to estimate the prevalence of generalized anxiety disorder in populations: a scoping review. PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12925687/
- Symptoms of Generalized Anxiety Disorder Among Adults. NCHS Data Brief, CDC. https://www.cdc.gov/nchs/products/databriefs/db378.htm
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.